UK markets closed

Taysha Gene Therapies, Inc. (TSHA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.2750-0.1350 (-5.60%)
As of 03:37PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1010109
Avg. Estimate-0.11-0.11-0.41-0.48
Low estimate-0.19-0.2-0.57-0.63
High estimate-0.07-0.08-0.3-0.35
Year ago EPS-0.28-0.38-0.96-0.41
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts9998
Avg. Estimate2.56M2.57M10.24M5.72M
Low estimateN/AN/AN/AN/A
High estimate4.5M4.5M18.1M15M
Year ago sales4.71M2.4M15.45M10.24M
Sales growth (year/est)-45.60%7.30%-33.70%-44.10%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.35-0.31-0.17-0.11
Actual EPS-0.28-0.38-0.930.92
Difference0.07-0.07-0.761.03
Surprise %20.00%-22.60%-447.10%936.40%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.11-0.11-0.41-0.48
7 days ago-0.11-0.11-0.4-0.48
30 days ago-0.06-0.06-0.44-0.49
60 days ago-0.06-0.06-0.44-0.52
90 days ago-0.06-0.06-0.44-0.61
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/A1N/A
Up last 30 daysN/AN/A1N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesTSHAIndustrySector(s)S&P 500
Current qtr.60.70%N/AN/AN/A
Next qtr.71.10%N/AN/AN/A
Current year57.30%N/AN/AN/A
Next year-17.10%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A